WHO IRISopen access
Improving access to medicines for neurological disorders
nervous system diseases, parkinson disease, epilepsy, drugs, essential, drug utilization, drug and narcotic control, drug costs, drug industry
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 270911
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.